MONIKA BENNER: Open Payments
NPI 1871081711 · MOKENA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,347 in 136 payments from 37 companies in 2025. Trend: 2023 $2,703 · 2024 $2,930 · 2025 $3,347
Food & beverage: $2,986Long term medical supply or device loan: $283Education: $78
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $756 |
| AstraZeneca Pharmaceuticals LP | 16 | $405 |
| ABBVIE INC. | 9 | $223 |
| PFIZER INC. | 12 | $186 |
| Astellas Pharma US Inc | 10 | $152 |
| ARRAY BIOPHARMA INC | 7 | $139 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $124 |
| Daiichi Sankyo Inc. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $90 |
Products named: KISQALI, VENCLEXTA, SCEMBLIX, ENHERTU, LYNPARZA, XTANDI, ZYNLONTA, CALQUENCE.
Industry payments across IL — which companies pay providers there.
